Bal Pharma Peer Comparison

NSE: BALPHARMA | BSE: 524824

₹105.02

₹-3.26 (-3.01%)

As on 24-Sep-2026IST

Market cap

₹167 Cr

Revenue (TTM)

₹334 Cr

P/E Ratio

23.1

P/B Ratio

Div. Yield

1.1 %

Edit

	Bal Pharma	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Market cap (₹ Cr)	167	21,783	19,712	17,683	18,517
Revenue (₹ Cr)	334	2,287	1,682	3,230	2,570
Net Profit (₹ Cr)	7.25	678.07	273.51	666.92	735.15
Net Margin (%)	2.16	28.10	16.19	20.60	26.88
RoE (%)	8.98	19.73	11.15	18.75	19.16
Price to Earnings	23.14	32.74	66.30	27.46	25.19
Price-To-Book	2.00	5.93	7.34	4.39	4.20

Income Statement (₹ Cr)

	Bal Pharma	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Operating Revenue	334.41	2,287.33	1,682.47	3,229.67	2,569.77
Total Income	336.05	2,413.29	1,689.83	3,237.12	2,735.39
Total Expenditure	300.62	1,490.75	1,203.91	2,090.06	1,628.14
EBITDA	33.79	796.58	478.55	1,139.61	941.63
Depreciation	11.34	78.10	126.01	281.06	57.58
EBIT	22.45	718.48	352.55	858.55	884.05
Interest	17.23	0.88	52.11	190.64	7.69
Other Income	1.64	125.96	7.37	7.45	165.62
Exceptional Items	0.00	0.00	12.16	-17.24	-49.16
Profit before Tax	6.86	843.56	319.96	658.12	992.82
Provision for Tax	-0.39	165.49	46.45	-8.80	257.67
Profit after Tax	7.25	678.07	273.51	666.92	735.15

	Bal Pharma	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Shareholder's Funds	82.23	3,586.42	2,591.20	3,902.67	4,202.90
Minority Interest	-0.04	-12.71	0.00	-21.81	0.00
Non-Current Liabilities	44.06	28.74	266.35	1,392.75	91.50
Current Liabilities	249.23	385.94	848.06	2,077.10	627.48
Total Liabilities	375.54	4,037.51	3,705.61	7,246.72	4,921.88

	Bal Pharma	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Non-Current Assets	102.23	1,291.22	2,525.44	5,617.77	770.28
Current Assets	262.23	2,585.66	1,109.77	1,539.85	3,803.22
Total Assets	375.54	4,037.51	3,705.61	7,246.72	4,921.88
Total Debt*	159.52	0.57	657.97	2,309.68	2.50
Net Current Assets	13.01	2,199.72	261.71	-537.25	3,175.74
Contingent Liabilities	5.58	17.53	160.01	51.57	370.49

	Bal Pharma	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Cash From Operating Activities	30.84	523.24	342.18	537.99	967.57
Cash Flow from Investing Activities	-20.70	-582.30	-325.92	-369.46	-561.67
Cash from Financing Activities	-9.59	-46.46	13.62	-313.53	-798.31
Net Cash Inflow / Outflow	0.55	-105.52	29.88	-145.00	-392.41

	Bal Pharma	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
ROCE (%)	9.78	24.97	11.43	14.47	23.39
ROE (%)	8.98	19.73	11.15	18.75	19.16
ROA (%)	2.04	18.69	7.80	9.26	14.95
EBIT Margin (%)	6.71	31.41	20.95	26.58	34.40
Net Margin (%)	2.16	28.10	16.19	20.60	26.88
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Bal Pharma	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Revenue Growth (%)	13.51	15.01	27.91	9.59	10.69
EBIT Growth (%)	16.36	18.45	58.32	16.84	24.14
Net Profit Growth (%)	0.86	19.61	149.56	62.68	-9.09
EPS Growth (%)	0.67	17.73	-3.57	67.41	14.40
Book Value Growth (%)	6.22	26.75	9.67	36.71	-0.34

	Bal Pharma	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Price / Earnings	23.09	32.65	71.18	26.77	24.05
Price / Book Value	2.00	5.91	7.43	4.39	4.21
Dividend Yield (%)	1.15	0.28	0.06	0.00	1.85
EV/EBITDA	9.37	26.01	42.97	17.48	16.40
Market Cap (₹ Cr)	95.74	11,439.22	6,819.66	17,980.08	21,592.90

	Bal Pharma	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Debt to Equity	0.39	0.00	0.07	0.24	0.00
Short term debt to equity ratio	1.37	0.00	0.16	0.12	0.00
Current Ratio	1.05	6.70	1.31	0.74	6.06
Quick Ratio	0.59	5.59	0.88	0.53	5.31
Interest Coverage	1.40	959.59	7.14	4.45	130.11

	Bal Pharma	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Debtors to sales (%)	28.00	36.10	30.84	21.07	7.07
Asset Turnover	0.94	0.63	0.48	0.45	0.52
Receivable days	108.96	121.68	113.81	63.88	26.06
Inventory Days	128.46	63.83	84.76	43.27	65.95
Payable days	219.58	108.28	101.94	151.85	81.01
Cash Conversion Cycle	17.84	77.23	96.62	-44.70	11.00

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.